Topics
March 2014 | Business Of Retina
The Use of Modifier Code -25 for Medicare and Medicaid Billing
Trexler M. Topping, MD
July 10, 2026
Opus Genetics Provides BEST1 Program Update
July 9, 2026
Biocon Announces Peer-Reviewed Data Supporting Yesafili in Diabetic Macular Edema
Teva, Samsung Bioepis Sign Canadian Commercialization Agreement for Aflibercept Biosimilar
Atsena Selects Lead Clinical Candidate for Stargardt Disease Gene Therapy
May/June 2026 Insert
Editorially Independent Content, Supported With Advertising From Astellas
Supported by Zeiss
Editorially independent supported by Abbvie and Regenxbio
May/June 2026 Supplement
Editorially independent content supported by advertising from Genentech
Free Print Subscription
Email Newsletter
Conference Calendar
